What Viroclinics Biosciences does

Viroclinics Biosciences is a Netherlands-headquartered contract research and clinical laboratory services company based in Rotterdam, founded in 2000. The firm operates in the specialized virology and vaccine laboratory testing space, providing diagnostic and preclinical study services that typically support pharmaceutical and biotechnology sponsors in clinical trial and drug development programs. With 251-500 employees, it sits in the mid-sized specialty lab segment rather than competing as a generalist central laboratory.

The company's leadership team is anchored by co-founder and Chief Scientific Officer Albert Osterhaus, a globally recognized virologist whose scientific standing underpins the firm's virology specialization. Operations are led by CEO Bob van Gemen, with Hans Bunschoten as COO and David van Hoytema as CFO. The company remains privately held and is positioned within the broader preclinical assets market, which third-party research (The Business Research Company) sizes at $10.2 billion by 2030 with a 9.8% CAGR, providing a favorable industry tailwind for a specialty lab services provider.

The available data does not disclose specific product catalog details, pricing models, named customer relationships, revenue mechanics, or technology stack for Viroclinics specifically. A large share of the supplied source material pertains to Cerba Research rather than Viroclinics and is therefore not used to characterize the company. This data gap limits granularity on go-to-market execution, customer concentration, and product-level differentiation, and is itself an important finding for due diligence.

Name

Viroclinics Biosciences

Website

https://viroclinics.com

Company type

Private

Founded year

2000

Headcount range

251–500 employees

Short description

Viroclinics Biosciences is a Rotterdam-based contract research organization founded in 2000 that provides diagnostic and preclinical virology and vaccine laboratory services to pharmaceutical and biotechnology sponsors.

Ownership category

akta.pro rank

Product category

Contract Research & Clinical Laboratory Services

NAICS

Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release) (HLAAAEAK)

Keywords

• Contract research services
• Clinical laboratory services
• Virology testing
• Vaccine development
• Preclinical research

Headquarters

HQ city

Rotterdam

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels5 records

Core offering

Viroclinics Biosciences is a contract research and clinical laboratory services provider delivering diagnostic and preclinical study support for vaccine, antiviral, and infectious disease programs. Services span virology and vaccine laboratory testing, anatomic pathology and tissue analysis, flow cytometry, genomics, immunoassay, biomarker and bioanalytical solutions, pre-clinical study support, and central/specialty clinical trial laboratory logistics through a global laboratory network.

Differentiator

Problem solved

Functional benefit

Products and services

• Anatomic Pathology & Tissue Analysis Specialty laboratory service covering digital imaging & analysis, immunohistochemistry (IHC), multiplex IHC & immunofluorescence, in-situ hybridization (ISH), and spatial omics (Nanostring GeoMx) for clinical trial and research use.
• Assay Development & Technology Transfer Service for developing custom laboratory assays and transferring assay technology to support clinical trial and research programs.
• Bioanalytical Solutions Bioanalytical testing services supporting drug development and clinical research.
• Biomarker Solutions Biomarker testing and development services for clinical trials and translational research.
• Flow Cytometry Services Flow cytometry panels and biomarkers, custom assay development, scientific project management, and reporting services for clinical trials and research.
• Genomics Services Genomics capabilities including constitutional genomics, DNA/RNA extraction, genomics for infectious diseases, immune repertoire sequencing, and next-generation sequencing for solid tumors, hematological malignancies, and liquid biopsies.
• Immunoassay Services Immunoassay laboratory testing for clinical trials and research programs.
• Pre-clinical Services Preclinical research services supporting drug and vaccine development programs prior to clinical trials.
• Pre-Analytical and PBMC Processing Sample pre-analytical processing and peripheral blood mononuclear cell (PBMC) processing for clinical and research use.
• Virology & Vaccine Laboratory Services Dedicated virology and vaccine laboratory services for vaccine, antiviral, and infectious disease development programs.
• Central & Specialty Clinical Trial Laboratory Solutions Central and specialty laboratory services for clinical trials across multiple therapeutic areas, including project management, protocol development, safety testing, and logistics.
• Biotech Lab Solution Central laboratory solution tailored to biotech sponsors running clinical trials.
• Global Laboratory Network Network of 42+ laboratories spanning five continents delivering specialty and central lab solutions for clinical trials globally.
• Specialty Diagnostic Kits Distribution of specialty diagnostic kits as part of central laboratory logistics for clinical trials.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• CalibrcoreStrategic or Co-development Partner · 1 July 2023US-based AbbVie extended its partnership with India's Calibr to jointly advance preclinical and early clinical assets. Calibr is part of Scripps Research. This partnership is mentioned in general preclinical market context, not as a Viroclinics partnership.
• Scripps ResearchcoreStrategic or Co-development Partner · 1 July 2023Calibr operates within the Scripps Research ecosystem. AbbVie's partnership with Calibr builds on an existing relationship with Scripps Research. This is general market information, not Viroclinics-specific.

Scale indicators1 record

Expansion highlights2 records

Broad incumbents

• ICON plc: Global CRO with central and specialty laboratory services supporting vaccine and infectious-disease clinical trials, an overlap with Viroclinics' clinical virology lab capabilities.
• Eurofins Scientific: International laboratory services group with dedicated clinical trial and pharma testing offerings including virology and vaccine assays, broadly comparable in lab-services model.
• Labcorp Drug Development (Covance): Global central and specialty lab services within a diversified CRO/Central lab platform; provides virology and vaccine trial support comparable to Viroclinics, alongside much broader offerings.
• Charles River Laboratories: Large preclinical CRO and specialty lab services provider with virology, vaccine and biologics safety testing capabilities, competing for many of the same preclinical and lab-service engagements as Viroclinics.
• PPD (Thermo Fisher Scientific): Global CRO with central and specialty lab services, including vaccine and infectious-disease trial support, comparable to Viroclinics' clinical-stage virology lab activities.
• SGS Life Sciences: Global contract laboratory and clinical research services provider with vaccine and biologics testing capabilities, comparable as a broad-based lab services peer.

Direct peers

• Q² Solutions: Clinical lab services joint venture (IQVIA/Quest) providing specialty biomarker, immunoassay, flow cytometry and vaccine/virology testing for clinical trials — highly comparable specialty lab peer.
• Eurofins Viracor: Specialty clinical laboratory focused on infectious disease, immunology, and vaccine-related testing for clinical trials and transplant services — directly comparable to Viroclinics' virology and vaccine specialty lab offering.
• Worldwide Clinical Trials: Mid-size global CRO with laboratory and scientific services supporting vaccine and infectious-disease trials, comparable in scale and therapeutic focus.
• Frontage Laboratories: Contract research and laboratory services organization providing preclinical, bioanalytical and specialty testing for biopharma — directly comparable as a mid-size specialty CRO/lab peer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/viroclinics-biosciences-bv

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viroclinics Biosciences